Patent holdings for IPC class A61K 31/7012

Total number of patents in this class: 311

10-year publication summary

18
36
19
25
13
22
23
20
12
10
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Glycom A/S
251
13
LifeScience AS
10
10
Regeneron Pharmaceuticals, Inc.
4394
7
MedImmune, LLC
499
6
The United States of America, as represented by the Secretary, Department of Health and Human Services
2895
6
Life Science Nutrition AS
12
5
Ultragenyx Pharmaceutical Inc.
183
5
Applied Biological Laboratories, Inc.
15
5
Shandong Zhonghai Pharmaceutical CO. LTD
8
5
The Regents of the University of California
20211
4
AMOREPACIFIC Corporation
2851
4
Australian Biomedical Company Pty Ltd.
5
4
Meiji Co., Ltd.
738
4
Nippon Zoki Pharmaceutical Co., Ltd.
143
4
Locus IP Company LLC
97
4
B & H Biotechnologies, LLC
16
4
Nestec S.A.
2638
3
ACP Japan Co., Ltd.
74
3
The Chancellor, Masters and Scholars of The University of Oxford
162
3
Curemark, LLC
74
3
Other owners 209